NightstaRx
Latest round
- Series C
Last raised
- Jun 2017
Total raised
- $120M
Investors
- 4
About NightstaRx
Founded in 2013 and based in London, UK, NightstaRx Limited operates as a developer of gene therapies for inherited retinal diseases such as choroideremia, X-linked retinitis pigmentosa, and best vitelliform macular dystrophy.
Who invested in NightstaRx
4 investors across 3 rounds
See all investors in NightstaRx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NightstaRx
Who invested in NightstaRx?
NightstaRx has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NightstaRx raised?
NightstaRx has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did NightstaRx last raise money?
NightstaRx's most recent round on record is a Series C, in Jun 2017.
What does NightstaRx do?
Founded in 2013 and based in London, UK, NightstaRx Limited operates as a developer of gene therapies for inherited retinal diseases such as choroideremia, X-linked retinitis pigmentosa, and best vitelliform macular dystrophy.
Where is NightstaRx headquartered?
NightstaRx is headquartered in London, UK.
Which VCs invest in companies like NightstaRx?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at NightstaRx's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like NightstaRx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.